Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Dexmedetomidine-Esketamine for Emergence Delirium in Elderly
NCT06566469Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and esketamine in emergence delirium (ED) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of emergence delirium after surgery. Started Sep 2024; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT06566469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06566469.